Long-term effect of prophylactic endoscopic injection sclerotherapy on liver function.Hepatogastroenterology. 1998 Sep-Oct; 45(23):1726-30.H
The aim of this study was to investigate the long term effect of prophylactic endoscopic injection sclerotherapy (EIS) on liver function.
This study was a retrospective investigation of seventy-eight patients with liver cirrhosis, whose liver function was classified as Child's A before follow-up. Laboratory data were retrospectively examined before and after follow-up, and a comparison was made between the EIS group (n=21) and the non-treated group (n=57).
In the 3 or more years of follow-up, cholinesterase and total cholesterol levels deteriorated in several severe-variceal cases. However, these levels did not deteriorate over the 3 or more years of follow-up in the EIS group.
Prophylactic endoscopic injection sclerotherapy among patients with early stage LC may prevent the deterioration of liver function.